MARIYA OSTERMILLER: Open Payments
NPI 1407047202 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 36 payments from 9 companies in 2025. Trend: 2023 $478 · 2024 $279 · 2025 $685
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 18 | $266 |
| Janssen Biotech, Inc. | 4 | $142 |
| Organon LLC | 6 | $77 |
| ABBVIE INC. | 2 | $56 |
| Kerecis Limited | 1 | $54 |
| GENZYME CORPORATION | 1 | $29 |
| Amgen Inc. | 2 | $28 |
| Incyte Corporation | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: NEMLUVIO, TREMFYA, SKYRIZI, Kerecis SurgiClose, DUPIXENT, OTEZLA, VTAMA, OPZELURA.
Industry payments across ID — which companies pay providers there.
